CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +4,226 | 29,419 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +437 | 29,856 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +867 | 30,723 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +1,348 | 32,071 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +12,400 | 44,471 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +1,148 | 45,619 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Grant or award · Performance Stock Units 10b5-1 | +12,679 | 12,679 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Performance Stock Units 10b5-1 | −4,226 | 8,453 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Performance Stock Units 10b5-1 | −437 | 0 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Performance Stock Units 10b5-1 | −867 | 0 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units 10b5-1 | −1,348 | 5,392 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units 10b5-1 | −12,400 | 24,802 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units 10b5-1 | −1,148 | 0 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise | +3,803 | 20,591 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise | +364 | 20,955 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise | +722 | 21,677 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise | +1,179 | 22,856 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise | +11,160 | 34,016 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise | +956 | 34,972 | ||
| 2024-03-01 | Trencher Daniel CHIEF STRATEGY OFFICER | Grant or award · Performance Stock Units | +11,411 | 11,411 |
Page 38 of 74 · 1,476 trades